Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation

Journal of Biomedical Materials Research - Part A

Volumn 86, Issue 1, 2008, Pages 137-148

  Seung, Rim Yang ^a   Seung, Beom Kim ^a   Joe, Cheol O ^a   Kim, Jong Duk ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Intracellular delivery; Oligoarginine; Poly(amino acid)s; Polymer peptide conjugate; Synthetic delivery carrier

Indexed keywords

AMINES; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; HEALTH; ORGANIC ACIDS;

DRUG CARRIERS; HELA CELLS; INTRACELLULAR DELIVERY; OLIGOARGININE; POLY(AMINO ACID);

AMINO ACIDS;

ARGININE DERIVATIVE; DRUG CARRIER; LIPOSOME; METHOTREXATE; OLIGOARGININE; POLY(2 HYDROXYTETHYL ASPARTAMIDE);

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ADSORPTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENDOCYTOSIS; FEMALE; HELA CELL; HUMAN; HUMAN CELL;

ADSORPTION; AMINO ACIDS; ARGININE; CELL PROLIFERATION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HELA CELLS; HUMANS; LIPOSOMES; MICROSCOPY, CONFOCAL; PEPTIDES; POLYHYDROXYETHYL METHACRYLATE; POLYMERS; TEMPERATURE;

EID: 44849111478     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31331     Document Type: Article

References (44)

1. Uhrich K, Cannizzaro S, Langer R, Shakesheff K. Polymeric systems for controlled drug release. Chem Rev 1999;99:3181-3198.
2. Jagur-Grodzinski J. Biomedical application of functional polymers. Reat Funct Polym 1999;39:99-138.
3. Nagarsekar A, Ghanehari H. Genetically engineered polymers for drug delivery. J Drug Target 1999;7:99-138.
4. Cavallaro G, Pitarresi G, Licciardi M, Giammona G. Polymeric prodrug for release of an antitumoral agent by specific enzymes. Bioconjug Chem 2001;12:143-151.
5. Mishra MK, Nuyken O, Kobayashi S, Yagci Y. Design of macromolecular prodrug forms of antitumor agents. In: Sar B, editor. Macromolecular Engineering: Recent Advances. New York: Plenum Press; 1995. p 101-116.
6. Matthews SE, Pouton CW, Threadgill MD. Macromolecular systems for chemotherapy and magnetic resonance imaging. Adv Drug Deliv Rev 1996;18:219-267.
7. Kataoka K. Targetable polymeric drugs. In: Park K, editor. Controlled Drug Delivery: Challenges and Strategies: American Chemical Society; 1997. p 49-71.
8. Kopecek J, Kopeckova P, Minko T, Lu ZR. HPMA copolymer-anticancer drug conjugates: Design, activity and mechanism of action. Eur J Pharm Biopharm 2000;50:61-81.
9. Duncan R. Drug-polymer conjugates: Potential for improved chemotherapy. Anticancer Drugs 1992;3:175-210.
10. De Marre A, Seymour LW, Schacht E. Evaluation of the hydrolytic and enzymatic stability of macromolecular mitomycin derivatives. J Control Release 1994;3:189-197.
11. Maeda H. Polymer conjugated macromolecular drugs for tumor-specific targeting. In: Domb AJ, editor. Polymeric Site-Specific Pharmacotherapy. New York: Wiley; 1995. p 95-116.
12. Christie RJ, Grainger DW. Design strategies to improve soluble macromolecular delivery constructs. Adv Drug Deliv Rev 2003;55:421-437.
13. Tung CH, Weissleder R. Arginine containing peptides as delivery vectors. Adv Drug Deliv Rev 2003;55:281-294.
14. Lindgren M, Hallbrink M, Prochiantz A, Langel U. Cell-penetrating peptides. Trends Pharmacol Sci 2002;21:99-103.
15. Nori A, Jensen KD, Tijerina M, Kopeckova P, Kopecek J. Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. Bioconjug Chem 2003;14:44-50.
16. Rothbard JB, Kreider E, VanDeusen CL, Wright L, Wylie BL, Wender PA. Arginine-rich molecular transporters for drug delivery: Role of backbone spacing in cellular uptake. J Med Chem 2002;45:3612-3618.
17. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 2000;56:318-325.
18. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S. Arginine-rich peptides: An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001;276:5836-5840.
19. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc Natl Acad Sci USA 2000;97:13003-13008.
20. Kang HS, Shin MS, Kim JD, Yang JW. Self-aggregate of poly (aspartic acid) grafted with long alkyl chain. Polym Bull 2000;45:39-43.
21. Kang HS, Yang SR, Kim JD, Han SH, Chang IS. Effect of grafted alkyl groups on aggregation behavior of amphiphilic poly(aspartic acid). Langmuir 2001;17:7501-7506.
22. Kang HS, Kim JD, Han SH, Chang IS. Self-aggregates of poly(2-hydroxyethyl aspartamide) copolymers loaded with methotexate by physical and chemical entrapment. J Control Release 2002;81:135-144.
23. Bae SK, Kim JD. Aggregation behaviors and their pH sensitivity ofcholesterol-conjugated proteinoids composed of glutamic acid and aspartic acid matrix. J Biomed Mater Res A 2003;64:282-290.
24. Jeong JH, Kang HS, Yang SR, Kim JD. Polymer micelle-like aggregates of novel amphiphilic biodegradable poly(asparagines) grafted with poly(caprolactone). Polymer 2003;44:583-591.
25. Yang SR, Jeong JH, Park K, Kim JD. Self-aggregates of hydrophobically modified poly(2-hydroxyethyl aspartamide) in aqueous solution. Colloid Polym Sci 2003;281:852-861.
26. Mendichi R, Giammona G, Cavallaro G, Schieroni AG. Molecular characterization of α,β-poly(N-hydroxyethyl DL-aspartamide) by light scattering and viscometry studies. Polymer 2000;41:8649-8657.
27. Fang G, Liu N. Determination of eight essential amino acids in mixtures by chemometrics-spectrophotometry without separation. Analyte Chim Acta 2001;445:245-253.
28. Fuchs SM, Raines RT. Pathway for polyarginine entry into mammalian cells. Biochemistry 2004;43:2438-2444.
29. Epand RF, Raguse TL, Gellman SH, Epand RM. Antimicrobial 14-helicalβ-peptides: Potent bilayer disrupting agents. Biochemistry 2004;43:9527-9535.
30. Thoren PEG, Persson D, Isakson P, Goksor M, Onfelt A, Norden B. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem Biophys Res Commun 2003;307:100-107.
31. Zorko M, Langel U. Cell-penetrating peptides: Mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 2005;57:529-545.
32. Gupta B, Levchenko TS, Torchilin VP. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 2005;57:637-651.
33. Foerg C, Ziegler U, Fernandes-Carneado J, Giralt E, Renner R, Beck-Sickinger AG, Merkle HP. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: Lipid raft-mediated endocytosis and endosomal escape. Biochemistry 2005;44:72-81.
34. Kaznessis YN, Kim S, Larson RG. Specific mode of interaction between compoments of model pulmonary surfactants using computor simulations. J Mol Biol 2002;322:569-582.
35. Futaki S, Goto S, Sugiura Y. Membrane permeability commonly shared among arginine-rich peptides. J Mol Recognit 2003;16:260-264.
36. Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem 2003;278:31192-31201.
37. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. Cell-penetrating peptides: A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003;278:585-590.
38. Vives E. Cellular uptake of the Tat peptide: An endocytosis mechanism following ionic interations. J Mol Recognit 2003;16:265-271.
39. Nori A, Kopecek J. Intracellular targeting of polymer-bound drugs for cancer chemotherapy. Adv Drug Deliv Rev 2005;57:609-636.
40. Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 2002;277:2437-2443.
41. Mai JC, Shen H, Watkins SC, Cheng T, Robbins P. Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J Biol Chem 2002;277:30208-30218.
42. Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparin sulfated proteoflycans. J Biol Chem 2002;276:3254-3261.
43. Belting M. Heparan sulfate proteoglycans as a plasma membrane carrier. Trends Biochem Sci 2003;28:145-151.
44. Futaki S. Arginine-rich peptides: Potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 2002;245:1-7.